Hematuria Treatment Cost Dynamics: Balancing Innovation with Accessibility for Patients Worldwide The hematuria treatment market is shaped by a delicate balance between the cost of innovative therapies and patients’ ability to access them. While advanced treatments like gene therapies for rare causes or AI-guided lithotripsy offer transformative benefits, their high price tags raise concerns about affordability, particularly in regions with strained healthcare systems. Addressing cost...